IP Library Granted Patent US 10,960,101
Granted Patent B2
US 10,960,101 · App. 15/841,843 · Granted Mar 30, 2021

Clay-based hemostatic agents

Inventors: Raymond J. Huey (Orange, CT); Denny Lo (Bethlehem, CT); Daniel J. Burns (Stratford, CT); Giacomo Basadonna (Haddam, CT); Francis X. Hursey (West Hartford, CT)
Assignee: Z-Medica, LLC
A61L15/44A61F13/00012A61F13/00063A61L15/18A61L15/28A61L15/425A61L2300/404A61L2300/406A61L2400/04A61L2400/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,101
App. No.
15/841,843
Granted
Mar 30, 2021
Kind
B2
Abstract

A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.

Claims (32)

1. A method for manufacturing a hemostatic device comprising:

providing an absorbent substrate;

applying a clay material that is distinct from the substrate to a surface of the substrate;

applying a binder comprising glycerol that is distinct from the substrate to the substrate to adhere at least a portion of the clay material to the surface of the substrate so that the surface is substantially free of loose clay;

wherein the clay material is positioned on the surface of the device in a region configured to contact blood from a bleeding wound, thereby promoting clotting;

wherein the hemostatic device is configured to absorb blood from the bleeding wound.

2. The method of claim 1 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, and combinations of the foregoing materials.

3. The method of claim 1 , wherein the clay comprises kaolin.

4. The method of claim 1 , wherein the clay material and the binder are applied as a single step.

5. The method of claim 1 , wherein the absorbent substrate is fabricated from a material selected from the group consisting of cotton, silk, wool, plastic, cellulose, rayon, polyester, and combinations of the foregoing.

6. The method of claim 1 , wherein the absorbent substrate is flexible to allow the absorbent substrate to form to a shape of the bleeding wound and to retain the shape of the bleeding wound.

7. The method of claim 1 , wherein the binder is applied to the absorbent substrate by a spraying process.

8. The method of claim 1 , wherein the binder and the clay material are applied to the absorbent substrate by a spraying process.

9. The method of claim 1 , wherein the binder is applied to the absorbent substrate by immersing the absorbent substrate in a liquid comprising the binder.

10. The method of claim 1 , wherein the binder and the clay material are applied to the absorbent substrate by a slot-die technique.

11. The method of claim 1 , wherein the binder and the clay material are applied to the absorbent substrate by rolling the binder and the clay material on the absorbent substrate.

12. A method for manufacturing a hemostatic device comprising:

providing an absorbent substrate;

applying a clay material that is distinct from the substrate to a surface of the substrate;

applying a binder comprising an alginate that is distinct from the substrate to a surface of the substrate to adhere at least a portion of the clay material to the surface of the substrate so that the surface is substantially free of loose clay;

wherein the clay material is positioned on the surface of the device in a region configured to contact blood from a bleeding wound, thereby promoting clotting;

wherein the hemostatic device is configured to absorb blood from the bleeding wound.

13. The method of claim 12 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, and combinations of the foregoing materials.

14. The method of claim 12 , wherein the clay comprises kaolin.

15. The method of claim 12 , wherein the clay material and the binder are applied as a single step.

16. The method of claim 12 , wherein the absorbent substrate is fabricated from a material selected from the group consisting of cotton, silk, wool, plastic, cellulose, rayon, polyester, and combinations of the foregoing.

17. The method of claim 12 , wherein the absorbent substrate is flexible to allow the absorbent substrate to form to a shape of the bleeding wound and to retain the shape of the bleeding wound.

18. The method of claim 12 , wherein the binder is applied to the absorbent substrate by a spraying process.

19. The method of claim 12 , wherein the binder and the clay material are applied to the absorbent substrate by a spraying process.

20. The method of claim 12 , wherein the binder is applied to the absorbent substrate by immersing the absorbent substrate in a liquid comprising the binder.

21. The method of claim 12 , wherein the binder and the clay material are applied to the absorbent substrate by a slot-die technique.

22. The method of claim 12 , wherein the binder and the clay material are applied to the absorbent substrate by rolling the binder and the clay material on the absorbent substrate.

Assignments (9)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
SECURITY INTEREST Recorded Mar 2, 2021
From: Z-MEDICA, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055455/0099 →
Continuity (11)
Continuation 15090072 · Apr 4, 2016
Continuation 14185873 · Feb 20, 2014
Continuation 13759963 · Feb 5, 2013
Continuation 13682085 · Nov 20, 2012
Continuation 13363270 · Jan 31, 2012
Continuation 12581782 · Oct 19, 2009
Continuation 11715057 · Mar 6, 2007
Continuation In Part 11590427 · Oct 30, 2006
Provisional Application 60808618 · May 26, 2006
Provisional Application 60810447 · Jun 1, 2006
Related Publication 20180104378A1 · Apr 19, 2018
Cited By (1)
US 12,685,799